OTC Medicines

Select an Issue

Browse OTC Medicines Content

Woman with smartphone and orange overlay. Text reads: For every $1 spent on over-the-counter medicines, the U.S. healthcare system saves $7.33.

Infographic

2022 OTC Value Study: $7.33 Saved for Every $1 Spent

Dec 1, 2022

Federal Register Notice graphic image with flag, capitol building, and gavel

Weekly Voice

Federal Register (FR) Notices, November 21, 2022

Summary Excerpts from Select Federal Register Notices for CHPA Weekly Voice for the Week of November 21, 2022

Nov 23, 2022

FDA headquarters sign in Washington DC

Press Releases and Statements

CHPA Submits Comments on FDA Proposed Rule for Nonprescription Drug Product With an Additional Condition for Nonprescription Use

CHPA Submits Comments on FDA Proposed Rule for Nonprescription Drug Product With an Additional Condition for Nonprescription Use

Nov 22, 2022

A picture of generic OTC medicines

Submission

Comments Regarding Proposed Rule for Nonprescription Drug Product With an Additional Condition for Nonprescription Use

CHPA appreciates the opportunity to provide input for Agency consideration as it works to finalize the regulations for ACNU.

Nov 21, 2022

DG Store Tags

Press Releases and Statements

CHPA Educational Foundation Launches First-Ever Pilot on OTC Pain Reliever Selection at Point of Purchase in Dollar General

The Consumer Healthcare Products Association (CHPA) Educational Foundation today announced an educational pilot launch to help consumers choose over-the-counter (OTC) pain relievers at the point of purchase

Nov 14, 2022

Weekly Voice Teaser

Weekly Voice

Congress Remains Uncertain After 2022 Midterm Elections

Nov 11, 2022

Weekly Voice Teaser

Weekly Voice

Mid-Term Elections Expand One-Party Control in Several States

Nov 11, 2022

Federal Register Notice graphic image with flag, capitol building, and gavel

Weekly Voice

Federal Register (FR) Notices, November 7, 2022

Nov 10, 2022

blue gloved hand holding blister packs

Submission

CHPA and PCPC Comments Regarding Content and Format of Labeling for Human Nonprescription Drug Products

In general, members are very satisfied with the existing regulations for content on the PDP, and recommend that no additional guidance on this topic is needed.

Nov 8, 2022

FDA headquarters sign in Washington DC

Submission

Comments Regarding Providing OTC Monograph Submissions in Electronic Format

This guidance provides information on providing electronic submissions to FDA under the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Nov 7, 2022

Filter Results